Prevalence and the associated factors of cognitive impairment among people living with HIV in Taiwan: a cross-sectional study

References

• Anand, P., Springer, S. A., Copenhaver, M. M., & Altice, F. L. (2010). Neurocognitive impairment and HIV risk factors: A reciprocal relationship. AIDS and Behavior, 14(6), 1213–1226. https://doi.org/10.1007/s10461-010-9684-1
   PubMed Web of Science ®Google Scholar
• Chen, C. H., Wang, L.-C., Ma, T.-C., & Yang, Y.-H. (2014). A walk-in screening of dementia in the general population in Taiwan. The Scientific World Journal, 2014, 243738. https://doi.org/10.1155/2014/243738
   Google Scholar
• Chen, H. H., Huang, H. L., Lin, C. M., & Wang, H. L. (2016). Association between metabolic syndrome and cognitive impairment among community-dwelling elderly in Taiwan. Taiwan Geriatrics & Gerontology, 11(4), 262–277. https://doi.org/10.29461/TGG.201611_11(4).0005
   Google Scholar
• Chin, R., Ng, A., Narasimhalu, K., & Kandiah, N. (2013). Utility of the AD8 as a self-rating tool for cognitive impairment in an Asian population. American Journal of Alzheimers Disease & Other Dementia, 28(3), 284–288. https://doi.org/10.1177/1533317513481090
   PubMed Web of Science ®Google Scholar
• Crum-Cianflone, N. F., Moore, D. J., Letendre, S., Poehlman Roediger, M., Eberly, L., Weintrob, A., Ganesan, A., Johnson, E., Del Rosario, R., Agan, B. K., & Hale, B. R. (2013). Low prevalence of neurocognitive impairment in early diagnosed and managed HIV-infected persons. Neurology, 80(4), 371–379. https://doi.org/10.1212/WNL.0b013e31827f0776
   PubMed Web of Science ®Google Scholar
• Davis, L. E., Hjelle, B. L., Miller, V. E., Palmer, D. L., Llewellyn, A. L., Merlin, T. L., Young, S. A., Mills, R. G., Wachsman, W., & Wiley, C. A. (1992). Early viral brain invasion in iatrogenic human immunodeficiency virus infection. Neurology, 42(9), 1736–1739. https://doi.org/10.1212/wnl.42.9.1736
   PubMed Web of Science ®Google Scholar
• Diaz, M. M., Zacarías, M. G., Sotolongo, P., Sanes, M. F., Franklin, D. J., Marquine, M. J., Cherner, M., Cárcamo, C., Ellis, R. J., Lanata, S., & García, P. J. (2021). Characterization of HIV-associated neurocognitive impairment in middle-aged and older persons with HIV in Lima, Peru. Frontiers in Neurology, 12, 629257. https://doi.org/10.3389/fneur.2021.629257
   PubMed Web of Science ®Google Scholar
• Galvin, J. E., Roe, C. M., Powlishta, K. K., Coats, M. A., Muich, S. J., Grant, E., Miller, J. P., Storandt, M., & Morris, J. C. (2005). The AD8: A brief informant interview to detect dementia. Neurology, 65(4), 559–564. https://doi.org/10.1212/01.wnl.0000172958.95282.2a
   PubMed Web of Science ®Google Scholar
• Mora-Peris, B., Stevens, E., Ferretti, F., Underwood, J., Taylor, S., & Winston, A. (2016). Evolution of changes in cognitive function after the initiation of antiretroviral therapy. AIDS Research and Therapy, 13, 20. https://doi.org/10.1186/s12981-016-0104-0.
   PubMed Web of Science ®Google Scholar
• Price, R. W., Spudich, S. S., Peterson, J., Joseph, S., Fuchs, D., Zetterberg, H., Gisslén, M., & Swanstrom, R. (2014). Evolving character of chronic central nervous system HIV infection. Seminars in Neurology, 34(1), 7–13. https://doi.org/10.1055/s-0034-1372337
   PubMed Web of Science ®Google Scholar
• Rodés, B., Cadiñanos, J., Esteban-Cantos, A., Rodríguez-Centeno, J., & Arribas, J. R. (2022). Ageing with HIV: Challenges and biomarkers. EBioMedicine, 77, 103896. https://doi.org/10.1016/j.ebiom.2022.103896
   PubMed Web of Science ®Google Scholar
• Sacktor, N., Saylor, D., Nakigozi, G., Nakasujja, N., Robertson, K., Grabowski, M. K., Kisakye, A., Batte, J., Mayanja, R., Anok, A., Gray, R. H., & Wawer, M. J. (2019). Effect of HIV subtype and antiretroviral therapy on HIV-associated neurocognitive disorder stage in Rakai, Uganda. Journal of Acquired Immune Deficiency Syndromes, 81(2), 216–223. https://doi.org/10.1097/qai.0000000000001992
   PubMed Web of Science ®Google Scholar
• Spudich, S., Gisslen, M., Hagberg, L., Lee, E., Liegler, T., Brew, B., Fuchs, D., Tambussi, G., Cinque, P., Hecht, F. M., & Price, R. W. (2011). Central nervous system immune activation characterizes primary human immunodeficiency virus 1 infection even in participants with minimal cerebrospinal fluid viral burden. The Journal of Infectious Diseases, 204(5), 753–760. https://doi.org/10.1093/infdis/jir387
   PubMed Web of Science ®Google Scholar
• Tai, S. Y., Huang, S. W., Hsu, C. L., Yang, C. H., Chou, M. C., & Yang, Y. H. (2014). Screening dementia in the outpatient department: Patients at risk for dementia. The Scientific World Journal, 2014, 138786. https://doi.org/10.1155/2014/138786
   Google Scholar
• Taiwan Centers for Disease Control. (2021, December 22). Statistics of HIV/AIDS. https://www.cdc.gov.tw/En/Category/MPage/kt6yIoEGURtMQubQ3nQ7pA
   Google Scholar
• Then, F. S., Luck, T., Angermeyer, M. C., & Riedel-Heller, S. G. (2016). Education as protector against dementia, but what exactly do we mean by education? Age and Ageing, 45(4), 523–528. https://doi.org/10.1093/ageing/afw049
   PubMed Web of Science ®Google Scholar
• Tsai, Y. T., Hsieh, C. Y., Lu, P. C., Ko, W. C., & Ko, N. Y. (2014). Nervous system disorders associated with HIV and syphilis Co-infection. Formosan Journal of Medicine, 18(5), 572–579. https://doi.org/10.6320/FJM.2014.18(5).11
   Google Scholar
• Watkins, C. C., & Treisman, G. J. (2015). Cognitive impairment in patients with AIDS - prevalence and severity. HIV AIDS (Auckl), 7, 35–47. https://doi.org/10.2147/hiv.S39665
   PubMedGoogle Scholar
• Webel, A. R., Schexnayder, J., Cioe, P. A., & Zuñiga, J. A. (2021). A review of chronic comorbidities in adults living with HIV: State of the science. The Journal of the Association of Nurses in AIDS Care: JANAC, 32(3), 322–346. https://doi.org/10.1097/JNC.0000000000000240
   PubMed Web of Science ®Google Scholar
• Wei, J., Hou, J., Su, B., Jiang, T., Guo, C., Wang, W., Zhang, Y., Chang, B., Wu, H., & Zhang, T. (2020). The prevalence of Frascati-criteria-based HIV-associated neurocognitive disorder (HAND) in HIV-infected adults: A systematic review and meta-analysis. Frontiers in Neurology, 11, 581346. https://doi.org/10.3389/fneur.2020.581346
   Web of Science ®Google Scholar
• Wing, E. J. (2016). HIV and aging. International Journal of Infectious Diseases, 53, 61–68. https://doi.org/10.1016/j.ijid.2016.10.004
   PubMed Web of Science ®Google Scholar
• Xie, Y., Gao, Y., Jia, J., Wang, X., Wang, Z., & Xie, H. (2014). Utility of AD8 for cognitive impairment in a Chinese physical examination population: A preliminary study. The Scientific World Journal, 2014, 804871. https://doi.org/10.1155/2014/804871
   Google Scholar
• Yang, Y. H., Galvin, J. E., Morris, J. C., Lai, C. L., Chou, M. C., & Liu, C. K. (2011). Application of AD8 questionnaire to screen very mild dementia in Taiwanese. American Journal of Alzheimers Disease & Other Dementia, 26(2), 134–138. https://doi.org/10.1177/1533317510397330
   PubMed Web of Science ®Google Scholar
• Yang, Y.-H., Liscic, R., & Dominguez, J. (2019). Framework of treating Alzheimer’s dementia. Brain Science Advances, 5(2), 82–93. https://doi.org/10.1177/2096595820902580
   Google Scholar
• Yen, Y. F., Chen, M., Jen, I. A., Chuang, P. H., Lee, C. Y., Lin, S. I., & Chen, Y. A. (2019). Short- and long-term risks of highly active antiretroviral treatment with incident opportunistic infections among people living with HIV/AIDS. Scientific Reports, 9(1), 3476. https://doi.org/10.1038/s41598-019-39665-6
   PubMedGoogle Scholar
• Yideg Yitbarek, G., Mossie Ayana, A., Bariso Gare, M., & Garedew Woldeamanuel, G. (2019). Prevalence of cognitive impairment and Its predictors among HIV/AIDS patients on antiretroviral therapy in Jimma University Medical Center, Southwest Ethiopia. Psychiatry Journal, 2019, 8306823. https://doi.org/10.1155/2019/8306823
   PubMedGoogle Scholar